Evidence map›Paper›PMID 41899837›Full record

ArticleBioengineering (Basel, Switzerland)2026

Segmentation Methodologies for the Construction of Hyperspectral Cell Nuclei Databases in Histopathology.

Gonzalo Rosa-Olmeda, Sara Hiller-Vallina, Manuel Villa, Berta Segura-Collar, Ricardo Gargini, Miguel Chavarrías

Abstract read
In one paragraph

Article in Bioengineering (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Gonzalo Rosa-OlmedaCEIMM, Center for Industrial Electronics & Multimodal Systems, Universidad Politécnica de Madrid, 28031 Madrid, Spain.ORCID 0000-0002-3236-1236
Sara Hiller-VallinaInstituto de Investigación Biomédicas I+12, Hospital Universitario 12 de Octubre, 28041 Madrid, Spain.ORCID 0000-0001-5973-9991
Manuel VillaCEIMM, Center for Industrial Electronics & Multimodal Systems, Universidad Politécnica de Madrid, 28031 Madrid, Spain.ORCID 0000-0001-7000-6289
Berta Segura-CollarInstituto de Investigación Biomédicas I+12, Hospital Universitario 12 de Octubre, 28041 Madrid, Spain.ORCID 0000-0001-8507-7434
Ricardo GarginiInstituto de Investigación Biomédicas I+12, Hospital Universitario 12 de Octubre, 28041 Madrid, Spain.ORCID 0000-0003-4032-0095
Miguel ChavarríasCEIMM, Center for Industrial Electronics & Multimodal Systems, Universidad Politécnica de Madrid, 28031 Madrid, Spain.ORCID 0000-0003-0280-3440

Funding

Instituto de Salud Carlos III PI22/01171; FI23/00281; CP21/00116; CP24/00062Ministerio de Ciencia, Innovación y Universidades PID2023-148285OB-C44
6 · The paper itself

Abstract

Hyperspectral imaging (HSI) extends conventional histopathology by combining spatial morphology with rich spectral information that reflects tissue biochemical composition, offering new opportunities for quantitative tissue analysis. However, reliable spectral analysis requires accurate instance-level segmentation of cell nuclei to enable the construction of meaningful nuclear spectral databases. In this work, a comprehensive methodology for generating hyperspectral databases of cell nuclei from histopathological samples is presented, including hyperspectral acquisition, preprocessing, nucleus segmentation, and spectral signature extraction. Three nucleus segmentation methods are evaluated: a spectral-only approach based on pixel-wise hyperspectral signatures in the visible-VNIR range; a spatial-only approach using synthetic RGB images derived from hyperspectral cubes; and a combined spatial-spectral approach that jointly exploits spatial and spectral information. The methods are assessed on a proprietary dataset of 30 hyperspectral cubes of tumor and healthy histopathological brain tissue annotated by expert pathologists. The spectral-only method achieves a Dice similarity coefficient (DSC) of 61.89% and produces severe over-segmentation, with cell count deviations exceeding substantially the ground truth in healthy tissue. The spatial-only method attains the highest pixel-wise accuracy (78.97% DSC) but underestimates nucleus counts by approximately 30% in tumor regions due to nucleus merging. The spatial-spectral method achieves a DSC of 73.13% and a mean cell count deviation of 4%, providing more reliable instance-level separation. These findings demonstrate that pixel-wise accuracy alone is insufficient for hyperspectral nuclear database generation.

Indexed as

biomedicinecomputer visiondeep learninghistopathologyhyperspectralmicroscopynuclei segmentationtumor

Identifiers

PMID41899837
PMCPMC13024104

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.